Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Arthritis / December 2005

Tip: Looking for answers? Try searching our database.

cleveland clinic demotes topol after testimony against merck

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
fresh~horses - 10 Dec 2005 06:25 GMT
Doctor Links Merck Trial to His Demotion

By ALEX BERENSON

December 10, 2005

Less than a week after his videotaped lambasting of Merck was played in
a Houston federal courthouse, Dr. Eric Topol, a prominent cardiologist,
has lost his title as chief academic officer of the Cleveland Clinic's
medical college.

~~~~~~~~~~~~~

In the courthouse yesterday, jurors continued deliberating whether
Merck's painkiller Vioxx had caused the death of a Florida main in
2001.

Dr. Topol said yesterday that he believed that his demotion might be
related to his testimony in that case, the third Vioxx lawsuit to reach
trial. Dr. Topol has questioned Vioxx's safety for years and said in
his testimony, played in court last Saturday, that he believed that
Merck acted irresponsibly and committed scientific misconduct when it
promoted Vioxx.

"The hardest thing in the world is just trying to tell the truth, to do
the right thing for patients, and you get vilified," he said yesterday.
"No wonder nobody stands up to the industry."

-----more----

http://www.nytimes.com/2005/12/10/business/10vioxx.html
Twittering One - 11 Dec 2005 06:13 GMT
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.